ES2181684T3 - Promotor del gen epidermico humano. - Google Patents

Promotor del gen epidermico humano.

Info

Publication number
ES2181684T3
ES2181684T3 ES93903613T ES93903613T ES2181684T3 ES 2181684 T3 ES2181684 T3 ES 2181684T3 ES 93903613 T ES93903613 T ES 93903613T ES 93903613 T ES93903613 T ES 93903613T ES 2181684 T3 ES2181684 T3 ES 2181684T3
Authority
ES
Spain
Prior art keywords
human
promoter elements
promoter
genes
tgase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93903613T
Other languages
English (en)
Inventor
Renata Regina Polakowska
Lowell Alan Goldsmith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp Technologies Inc
Original Assignee
Research Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp Technologies Inc filed Critical Research Corp Technologies Inc
Application granted granted Critical
Publication of ES2181684T3 publication Critical patent/ES2181684T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

EL INVENTO SE RELACIONA CON ELEMENTOS PROMOTORES DE GENES HUMANOS DE TRANSGLUTAMINASA TIPO I (TGASA I) PARA EXPRESION DE GEN CONTROLODA DE TGASA I HUMANA Y PROTEINAS HETEROLOGAS. LOS ELEMENTOS PROMOTORES PERMITEN LA EXPRESION ESPECIFICA DE TEJIDO DE LOS GENES, POR EJ., PARA USO EN TERAPIA DE GENES HUMANOS Y PARA EVALUACION DE AGENTES FARMACEUTICOS CON PIEL ARTIFICIAL. ADICIONALMENTE, LOS ELEMENTOS PROMOTORES INDIVIDUALES PUEDEN PROPORCIONAR REGULACION DIFERENCIAL EN CONDICIONES FISIOLOGICAS O EN PRESENCIA DE FACTORES EXOGENAMENTE AÑADIDOS INCLUYENDO CALCIO Y ACIDO RETINOICO.
ES93903613T 1992-01-23 1993-01-22 Promotor del gen epidermico humano. Expired - Lifetime ES2181684T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82693192A 1992-01-23 1992-01-23

Publications (1)

Publication Number Publication Date
ES2181684T3 true ES2181684T3 (es) 2003-03-01

Family

ID=25247882

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93903613T Expired - Lifetime ES2181684T3 (es) 1992-01-23 1993-01-22 Promotor del gen epidermico humano.

Country Status (7)

Country Link
US (1) US5643746A (es)
EP (1) EP0625206B1 (es)
JP (2) JP3430296B2 (es)
AT (1) ATE225852T1 (es)
DE (1) DE69332373T2 (es)
ES (1) ES2181684T3 (es)
WO (1) WO1993015209A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1088067A4 (en) 1998-06-26 2002-09-25 Univ Virginia TECHNIQUES AND COMPOSITIONS FOR MODULATING SPERMATOGENESIS
US20030219416A1 (en) * 2002-05-24 2003-11-27 Marcia Simon Long-lived keratinocytes
US20060147429A1 (en) * 2004-12-30 2006-07-06 Paul Diamond Facilitated cellular reconstitution of organs and tissues
US20060148080A1 (en) * 2004-12-30 2006-07-06 Paul Diamond Methods for supporting and producing human cells and tissues in non-human mammal hosts
US20090017517A1 (en) * 2007-07-13 2009-01-15 Medimmune, Llc Preparation of Negative-Stranded RNA Viruses by Electroporation
MX2010003371A (es) 2007-09-28 2010-05-05 Intrexon Corp Constructos interruptores genicos terapeuticos y biorreactores para la expresion de moleculas bioterapeuticas y usos de los mismos.
CN105950543A (zh) * 2016-07-19 2016-09-21 安徽惠恩生物科技股份有限公司 一种表皮细胞的扩增制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888291A (en) * 1987-06-19 1989-12-19 President And Fellows Of Harvard College Human epithelium originating from cell cultures

Also Published As

Publication number Publication date
US5643746A (en) 1997-07-01
DE69332373T2 (de) 2003-06-18
WO1993015209A1 (en) 1993-08-05
JP3430296B2 (ja) 2003-07-28
ATE225852T1 (de) 2002-10-15
JP2003159089A (ja) 2003-06-03
EP0625206A1 (en) 1994-11-23
JPH07505764A (ja) 1995-06-29
EP0625206B1 (en) 2002-10-09
DE69332373D1 (de) 2002-11-14

Similar Documents

Publication Publication Date Title
Morton et al. Collagen polymorphism in the normal and diseased blood vessel wall: investigation of collagens types I, III and V
Leco et al. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues.
ATE336240T1 (de) Therapeutische verwendung von stickstoffmonoxydinhibitoren
ATE312190T1 (de) Nukleinsaeure enthaltende zusammensetzungen, herstellung und verwendung
KR850007275A (ko) 기능성 인체인자 ⅷ의 제조방법
EP0591385A4 (en) Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
DE69534878D1 (de) Neuartige adenovirale vektoren, verpackungsszellinien, rekombinante adenoviren und verfahren
ATE196428T1 (de) Verwendung von gentisinsäure oder gentisylalkohol zur stabilisierung von radio-markierten peptiden und proteinen
HUP9902310A2 (hu) Komplementer adenovírus-vektorrendszerek és sejtvonalak
NO176921C (no) Genteknologisk fremgangsmåte for fremstilling av et tPA-lignende protein, samt vertscelle som er i stand til å uttrykke et slikt protein
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
ATE120757T1 (de) Diagnostischer test für plasminogenaktivatoren vom gewebs- und urokinasetyp und dafür kodierende gene.
Rosenbloom et al. Inhibition of proline hydroxylation does not inhibit secretion of tropoelastin by chick aorta cells
DE69534180D1 (de) Promotor der tie rezeptor protein kinase
ES2181684T3 (es) Promotor del gen epidermico humano.
HU9300397D0 (en) Method for modifying tropism of micor-organisms to cells, tissues and host organisms recombinant micro-organisms obtained by this way and their application in human and veterinary medicine
DK1147205T3 (da) Hej-effektive mammale genekspressionsvektorer, som indeholder eksogen promotor og hele den 5'-ikke-translaterede regions opstroms for startcodonet for inherent gen som transkriptionsregulatorisk sted
ATE174629T1 (de) Herstellung von proteinen mittels protein 7b2
DK0948536T3 (da) G-protein-koblet receptor med et forstörret extracellulært domæne
Soyombo et al. Stable expression of human platelet-derived growth factor B chain by bovine aortic endothelial cells. Matrix association and selective proteolytic cleavage by thrombin
JPS642572A (en) Polypeptide, dna and use thereof
HUP9802587A2 (hu) Glükózzal indukálható rekombináns virális vektor, ezt tartalmazó gyógyszerkészítmény és ezzel transzformált sejtek
ATE151777T1 (de) Modifizierter plättchenfaktor-4
ATE44750T1 (de) Verfahren zur herstellung eines antihaemophiliefaktor-konzentrats.
Bomalaski et al. Rheumatoid arthritis synovial fluid phospholipase A2 activating protein (PLAP) stimulates human neutrophil degranulation and superoxide ion production